Oct 13
About 1 in 5 women* will experience early pregnancy loss, also known as miscarriage, and often in the first 12 weeks. Pregnant and birthing people face enormous and unacceptable stigma and shame when they experience a pregnancy loss, and are often not encouraged to talk about their loss. This stigma silences people’s voices, leads to…
Sep 15
As oral arguments at the Supreme Court for Dobbs v. Jackson Women’s Health Center draw closer, our friends at We Testify and Advocates for Youth are putting together The People’s Brief, an amicus brief that elevates the stories and experiences of people who have had abortions. This brief will be submitted to the Supreme Court…
Aug 04
Join us in welcoming our new summer interns, Hayley and Marho! Hayley Farless McMahon, Research Intern Hayley (she/her) is joining us as our Research Intern. Hayley is a Master of Science in Public Health (MSPH) at Johns Hopkins Bloomberg School of Public Health. She is a proud first-generation college graduate with a degree in Cultural…
Jul 28
Telehealth Care for Medication Abortion During the COVID-19 pandemic, many health centers and clinicians rapidly transitioned and innovated in order to provide high-quality medication abortion care with minimal interpersonal interaction to protect against virus transmission. This involved forgoing ultrasound in patients without explicit need for it, counseling via telehealth, taking at-home pregnancy tests, offering remote…
Jul 20
Legal Round Up: What a Year! 2021 is on track to be the worst legislative session for abortion restrictions in decades. Since January, 549 abortion restriction bills have been introduced in 47 states, and 69 of them have been enacted. Worst of all, in May the Supreme Court announced it would hear Dobbs v. Jackson…
Jul 14
Using Science and Evidence to Push FDA to Review Mifepristone REMS Mifepristone with misoprostol is a safe, effective way to provide abortion and early pregnancy loss (EPL) care. Yet, the US Food and Drug Administration (FDA) heavily and unnecessarily regulates mifepristone under a Risk Evaluation and Mitigation Strategy (REMS). These restrictions limit where and who…
Jul 09
Our Team is Growing! The RHAP team keeps on growing! Meet our new Program Coordinator and Development Intern, Brandy and Piper! Brandy Bautista, Program Coordinator Brandy (she/her) joined us at the end of May as our Program Coordinator. Brandy graduated from California State University with a BA in Women and Gender Studies and has…
Jun 17
Today, June 8th, marks the official reintroduction of the Women’s Health Protection Act (WHPA)! This groundbreaking piece of federal legislation works towards a future where everyone, everywhere is free to make the personal decisions that shape their lives, futures, and families, without political or legislative interference. And the timing has never been more urgent, as state…
Jun 16
This month we come together in celebration of Pride! Pride month, hosted each year in June, honors the dynamic and resilient LGBTQIA+ community and commemorates the 1969 Stonewall riots – a night of resistance foundational to the modern-day gay liberation movement. While June is a period for celebration, community, and love, we also recognize the barriers that…
Jun 02
Did you know that fewer than 6% of family medicine residency programs provide training in comprehensive reproductive health care? This means most people can’t see their primary care provider for basic health services like contraception and early pregnancy loss care. RHAP’s Reproductive Health Care and Advocacy Fellowship helps fill this gap in clinical education. The…